Evidence map›Paper›PMID 37207226›Full record

ArticleFrontiers in immunology2023

Reduced immunogenicity of a live

Jessica C Allen, Franklin R Toapanta, Scott M Baliban, Marcelo B Sztein, Sharon M Tennant

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Multivalent vaccines for invasiveInfection and immunity · 2026
    Review
  2. Article
  3. Review
  4. Deletion of an immune evasion gene,Frontiers in immunology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jessica C AllenCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Franklin R ToapantaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Scott M BalibanCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Marcelo B SzteinCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Sharon M TennantCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
University of Maryland, Baltimore · US

Funding

Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni diseaseU19AI142725 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2019 to 2023
$12.5M
FELLOWSHIP TRAINING PROGRAM IN VACCINOLOGYT32AI007524 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Marcelo B. Sztein · 1997 to 2026
$6.4M
NIAID NIH HHS T32 AI007524NIAID NIH HHS U19 AI142725
6 · The paper itself

Abstract

Introduction: Non-typhoidal Methods: In this study, adult (six-to-eight-week-old) and aged (18-month-old) C57BL/6 mice received two doses of CVD 1926 (10 Results: Compared to PBS-immunized mice, adult mice immunized with CVD 1926 had significantly lower Conclusion: These data suggest that our candidate live attenuated

Indexed as

Cardiovascular DiseasesSalmonella entericaSalmonella InfectionsSalmonella VaccinesTyphoid-Paratyphoid VaccinesAgedAnimalsHumansInfantMiceMice, Inbred C57BLSalmonella typhimuriumSerogroupTumor Necrosis Factor-alphaVaccines, AttenuatedSalmonella VaccinesTumor Necrosis Factor-alphaTyphoid-Paratyphoid VaccinesVaccines, Attenuatedagedimmunosenescencelive-attenuatedSalmonellavaccine

Identifiers

PMID37207226
PMCPMC10188964
OpenAlexW4368377143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.